MA26630A1 - 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents
4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenantInfo
- Publication number
- MA26630A1 MA26630A1 MA25582A MA25582A MA26630A1 MA 26630 A1 MA26630 A1 MA 26630A1 MA 25582 A MA25582 A MA 25582A MA 25582 A MA25582 A MA 25582A MA 26630 A1 MA26630 A1 MA 26630A1
- Authority
- MA
- Morocco
- Prior art keywords
- phenylpyperidines
- novel
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810671.9A GB9810671D0 (en) | 1998-05-18 | 1998-05-18 | Anti-pruritic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26630A1 true MA26630A1 (fr) | 2004-12-20 |
Family
ID=10832267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25582A MA26630A1 (fr) | 1998-05-18 | 1999-05-17 | 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant |
Country Status (18)
Country | Link |
---|---|
US (1) | US6610711B2 (fr) |
EP (1) | EP1077940B1 (fr) |
JP (1) | JP2002515486A (fr) |
AP (1) | AP9901535A0 (fr) |
AT (1) | ATE271038T1 (fr) |
AU (1) | AU3531299A (fr) |
BR (1) | BR9910609A (fr) |
CA (1) | CA2332538C (fr) |
DE (1) | DE69918687T2 (fr) |
DK (1) | DK1077940T3 (fr) |
ES (1) | ES2230846T3 (fr) |
GB (1) | GB9810671D0 (fr) |
GT (1) | GT199900067A (fr) |
MA (1) | MA26630A1 (fr) |
PT (1) | PT1077940E (fr) |
TN (1) | TNSN99095A1 (fr) |
WO (1) | WO1999059971A1 (fr) |
ZA (1) | ZA993364B (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9912415D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912411D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912416D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912417D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912410D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
US6727264B1 (en) | 2001-07-05 | 2004-04-27 | Synaptic Pharmaceutical Corporation | Substituted anilinic piperidines as MCH selective antagonists |
HUP0401880A2 (hu) * | 2001-07-05 | 2005-01-28 | Synaptic Pharmaceutical Corporation | Helyettesített anilin-piperidinek mint MCH-szelektív antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
AU2002329557B2 (en) * | 2001-10-22 | 2008-07-31 | Pfizer Products Inc. | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
WO2003043987A2 (fr) * | 2001-11-19 | 2003-05-30 | Elan Pharmaceuticals, Inc. | Piperidines et piperazines 3,4-disubstituees, 3,5-disubstituees et 3,4,5-substituees |
ES2201908B1 (es) * | 2002-05-29 | 2005-02-16 | Laboratorios Del Dr. Esteve, S.A. | Pienso suplementado con ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea. |
JP3984281B2 (ja) * | 2003-04-14 | 2007-10-03 | ファイザー・プロダクツ・インク | 3−アザビシクロ〔3,2,1〕オクタン誘導体 |
FR2872416B1 (fr) * | 2004-07-01 | 2006-09-22 | Oreal | Utilisation de derives de piperidine pour lutter contre les rides |
CA2597956C (fr) * | 2005-02-17 | 2013-07-09 | Velcera Pharmaceuticals | Administration par voie transmuqueuse de compositions medicamenteuses pour le traitement et la prevention de troubles chez les animaux |
CA2632030A1 (fr) * | 2005-12-15 | 2007-06-21 | Boehringer Ingelheim International Gmbh | Composes qui modulent le recepteur cb2 |
MY145633A (en) | 2006-03-01 | 2012-03-15 | Theravance Inc | 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
JP5448164B2 (ja) * | 2006-07-28 | 2014-03-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を変調する化合物 |
MX2009002888A (es) * | 2006-09-25 | 2009-03-31 | Boehringer Ingelheim Int | Compuestos que modulan el receptor cb2. |
TWI409067B (zh) * | 2007-02-28 | 2013-09-21 | Theravance Inc | 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型 |
TWI423801B (zh) | 2007-08-27 | 2014-01-21 | Theravance Inc | 作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物 |
US7947710B2 (en) * | 2007-08-27 | 2011-05-24 | Theravance, Inc. | Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
EP2185553B1 (fr) * | 2007-08-27 | 2012-06-27 | Theravance, Inc. | Composés d'amidoalkyle-8-azabicyclo[3.2.1]octane en tant qu'antagonistes du récepteur opioïde mu |
ES2465621T3 (es) * | 2007-08-27 | 2014-06-06 | Theravance, Inc. | Compuestos de heteroarilalquil-8-azabiciclo[3.2.1]octano, como antagonistas de los receptores opiodes mu |
JP5492092B2 (ja) * | 2007-11-07 | 2014-05-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を調節する化合物 |
US8178568B2 (en) * | 2008-07-10 | 2012-05-15 | Boehringer Ingelheim International Gmbh | Sulfone compounds which modulate the CB2 receptor |
AU2009296838A1 (en) * | 2008-09-25 | 2010-04-01 | Boehringer Ingelheim International Gmbh | Sulfonyl compounds which selectively modulate the CB2 receptor |
US8299103B2 (en) | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
EP2443107B1 (fr) | 2009-06-16 | 2018-08-08 | Boehringer Ingelheim International GmbH | Dérivés d'azétidine 2-carboxamide qui modulent le récepteur cb2 |
JP2013505295A (ja) * | 2009-09-22 | 2013-02-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を選択的に調節する化合物 |
WO2011088015A1 (fr) | 2010-01-15 | 2011-07-21 | Boehringer Ingelheim International Gmbh | Composés qui modulent le récepteur cb2 |
JP5746228B2 (ja) | 2010-03-05 | 2015-07-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を選択的に調節するテトラゾール化合物 |
JP5746764B2 (ja) | 2010-07-22 | 2015-07-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を調節する化合物 |
EP2803668A1 (fr) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Nouveau (cyano-dimethyl-methyl)-isoxazoles et - [1,3,4] thiadiazoles |
CN106278914B (zh) * | 2016-08-19 | 2018-04-13 | 四川福思达生物技术开发有限责任公司 | 一种增产胺的合成工艺 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR206937A1 (es) * | 1974-09-06 | 1976-08-31 | Lilly Co Eli | Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina |
CA1321792C (fr) * | 1987-04-16 | 1993-08-31 | Eli Lilly And Company | Antagonistes d'opioides a base de piperidine |
US5159081A (en) * | 1991-03-29 | 1992-10-27 | Eli Lilly And Company | Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists |
NZ242117A (en) * | 1991-03-29 | 1994-11-25 | Lilly Co Eli | 4-phenylpiperidine derivatives and medicaments containing them |
GB9507203D0 (en) * | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
JP2001526643A (ja) * | 1997-04-18 | 2001-12-18 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5ht1a、5ht1bおよび5ht1d受容体アンタゴニスト活性を合わせ持つ化合物を含む二環式アリールまたは二環式複素環 |
-
1998
- 1998-05-18 GB GBGB9810671.9A patent/GB9810671D0/en not_active Ceased
-
1999
- 1999-05-13 AP APAP/P/1999/001535A patent/AP9901535A0/en unknown
- 1999-05-14 GT GT199900067A patent/GT199900067A/es unknown
- 1999-05-17 ES ES99917038T patent/ES2230846T3/es not_active Expired - Lifetime
- 1999-05-17 DE DE69918687T patent/DE69918687T2/de not_active Expired - Fee Related
- 1999-05-17 EP EP99917038A patent/EP1077940B1/fr not_active Expired - Lifetime
- 1999-05-17 AT AT99917038T patent/ATE271038T1/de not_active IP Right Cessation
- 1999-05-17 JP JP2000549590A patent/JP2002515486A/ja active Pending
- 1999-05-17 CA CA002332538A patent/CA2332538C/fr not_active Expired - Fee Related
- 1999-05-17 MA MA25582A patent/MA26630A1/fr unknown
- 1999-05-17 US US09/646,255 patent/US6610711B2/en not_active Expired - Fee Related
- 1999-05-17 TN TNTNSN99095A patent/TNSN99095A1/fr unknown
- 1999-05-17 ZA ZA9903364A patent/ZA993364B/xx unknown
- 1999-05-17 WO PCT/IB1999/000886 patent/WO1999059971A1/fr active IP Right Grant
- 1999-05-17 DK DK99917038T patent/DK1077940T3/da active
- 1999-05-17 PT PT99917038T patent/PT1077940E/pt unknown
- 1999-05-17 AU AU35312/99A patent/AU3531299A/en not_active Abandoned
- 1999-05-17 BR BR9910609-4A patent/BR9910609A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU3531299A (en) | 1999-12-06 |
ES2230846T3 (es) | 2005-05-01 |
WO1999059971A1 (fr) | 1999-11-25 |
JP2002515486A (ja) | 2002-05-28 |
PT1077940E (pt) | 2004-10-29 |
ATE271038T1 (de) | 2004-07-15 |
CA2332538A1 (fr) | 1999-11-25 |
EP1077940B1 (fr) | 2004-07-14 |
DE69918687D1 (de) | 2004-08-19 |
US20030078282A1 (en) | 2003-04-24 |
CA2332538C (fr) | 2005-08-02 |
GT199900067A (es) | 2000-11-04 |
ZA993364B (en) | 2000-12-01 |
BR9910609A (pt) | 2001-01-09 |
EP1077940A1 (fr) | 2001-02-28 |
DE69918687T2 (de) | 2005-07-28 |
DK1077940T3 (da) | 2004-11-01 |
GB9810671D0 (en) | 1998-07-15 |
US6610711B2 (en) | 2003-08-26 |
TNSN99095A1 (fr) | 2005-11-10 |
AP9901535A0 (en) | 1999-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26630A1 (fr) | 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26622A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
FR2780057B1 (fr) | Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26687A1 (fr) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26654A1 (fr) | Pyrrolopyrimidines nouvelles procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA24529A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant . | |
MA26598A1 (fr) | 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur préparation et compositions pharmaceutiques les contenant | |
DZ2890A1 (fr) | 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
MA26472A1 (fr) | Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26669A1 (fr) | 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26468A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26686A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26424A1 (fr) | Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26479A1 (fr) | Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26653A1 (fr) | Pyrrolo [2,3- d] pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26559A1 (fr) | Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation | |
MA26499A1 (fr) | Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant . | |
MA26508A1 (fr) | Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation. | |
MA26433A1 (fr) | Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26430A1 (fr) | 4 (3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26558A1 (fr) | Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26740A1 (fr) | Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26624A1 (fr) | Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26707A1 (fr) | Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26519A1 (fr) | Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant. |